AMPHIREGULIN PROCESSING IN HUMAN KERATINOCYTES
AMPHIREGULIN PROCESSING IN HUMAN KERATINOCYTES
批准号:
6325737
负责人:
PETER J DEMPSEY
金额:
$8.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-05-01 至 2001-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Amphiregulin (AR) is a member of the epidermal growth factor receptor
(EGFR) family of ligands. In cultured human keratinocytes, amphiregulin
is the major is the major autocrine growth factor. Additionally, the
mitogenic effects on AR on keratinocytes can be enhanced by interaction
with other proteins such as CD9 and are inhibited by heparin. Although
the role of AR in normal adult epidermis is not completely understood,
analysis adult epidermis is not completed understood, analysis of AR
protein and mRNA levels has provided some insights into its function. AR
is weakly expressed in keratinocytes in normal adult epidermis but is
up-regulated in several hyperproliferative disorders such as psoriasis
and in tumors. A possible causal link between elevated AR levels and
psoriasis has been suggested by the recent finding that transgenic mice
over-expressing human AR cDNA under the K14 keratin promoter display a
psoriatic phenotype. The result stands in direct contrast to the effects
of TGFalpha over-expression, suggesting distinct roles for these two
ligands. Moreover, AR, but not TGFalpha, is dramatically induced (10-30
fold) in several wounding models.
Amphiregulin is synthesized as a glycosylated membrane-anchored
precursor (proAR). In polarized epithelial cells, we have examined the
biosynthesis and processing of proAR and demonstrated complex sequential
processing of proAR ectodomain to produce multiple cellular and soluble
AR forms. A predominant 43 kD soluble AR form is novel, contains the N-
terminal pro-region and has a c-terminal extension. The biological
significance of multiple AR species is not known. The goals of this
grant proposal are to identify the cellular and soluble forms of AR
produced in normal keratinocytes. These studies will be the first to
comprehensively examine proAR biosynthesis and processing in a normal
primary epithelial cell type. The mechanism(s) involved in regulating
proAR ectodomain cleavage in keratinocytes will also provide the basis
for understanding the role of metalloproteases in this process and more
generally in the process of membrane shedding. Finally, these studies
should enhance our understanding of the role of the various AR forms
expressed under different environmental conditions (e.g., UV exposure)
and in different skin disease states.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Disease Modeling Core
-
批准号:10392981
-
项目类别:
-
资助金额:$17.82万
-
财政年份:2020
-
负责人:PETER J DEMPSEY
-
依托单位:
ADAM10 in Intestinal Homeostasis and Regeneration
-
批准号:8734396
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2012
-
负责人:PETER J DEMPSEY
-
依托单位:
ADAM10 in Intestinal Homeostasis and Regeneration
-
批准号:8475585
-
项目类别:
-
资助金额:$29.18万
-
财政年份:2012
-
负责人:PETER J DEMPSEY
-
依托单位:
ADAM10 in Intestinal Homeostasis and Regeneration
-
批准号:9108378
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2012
-
负责人:PETER J DEMPSEY
-
依托单位:
ADAM10 in Intestinal Homeostasis and Regeneration
-
批准号:8371729
-
项目类别:
-
资助金额:$30.44万
-
财政年份:2012
-
负责人:PETER J DEMPSEY
-
依托单位:
Development of ADAM10 Prodomain as a Therapeutic Agent
-
批准号:7674433
-
项目类别:
-
资助金额:$10.74万
-
财政年份:2009
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:7091459
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:6574863
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:6897432
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:6779889
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Endogenous Betacellulin Signaling in Beta-cell Biology
-
批准号:6665328
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2002
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6785414
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6613839
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6345608
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:7116696
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6382025
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
Processing of EGF Ligands in Gut Biology and Cancer
-
批准号:6524534
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2000
-
负责人:PETER J DEMPSEY
-
依托单位:
AMPHIREGULIN PROCESSING IN HUMAN KERATINOCYTES
-
批准号:6100584
-
项目类别:
-
资助金额:$8.53万
-
财政年份:1999
-
负责人:PETER J DEMPSEY
-
依托单位:
AMPHIREGULIN PROCESSING IN HUMAN KERATINOCYTES
-
批准号:6268401
-
项目类别:
-
资助金额:$6.66万
-
财政年份:1998
-
负责人:PETER J DEMPSEY
-
依托单位:
海外基金